From: Neuropsychological assessment in the Israeli healthcare system: a practitioners’ survey
Question | Response frequency |
---|---|
Which type of patients could benefit from NPA? (list syndromes) | N = 237 |
Traumatic brain injury | 188 (79%) |
Brain tumors or other cancer | 63 (27%) |
Stroke | 53 (22%) |
Attention deficit disorder | 52 (22%) |
Epilepsy | 50 (21%) |
Dementia | 48 (20%) |
What characterizes individuals who could benefit from NPA? | N = 129 |
A relevant disease | 86 (67%) |
Rehabilitation potential | 60 (47%) |
Younger age | 44 (34%) |
Changes in cognitive state | 42 (33%) |
Feasibility of return to work | 27 (21%) |
Higher motivation | 16 (12%) |
What are the advantages of NPA over other cognitive evaluations? | N = 155 |
Integration | 95 (61%) |
Expertise | 70 (45%) |
Breadth | 51 (33%) |
Depth | 37 (24%) |
Interpretation | 13 (8%) |
What are the disadvantages of NPA over other cognitive evaluations? | N = 130 |
Report length | 63 (48%) |
Cost/price | 53 (41%) |
Turnaround time | 48 (37%) |
Relevance to functioning | 21 (16%) |
Reliability | 13 (10%) |